October 5, 2011
Ono Pharmaceutical announced on October 4 that it had finalized two licensing agreements with Germany’s Merck KGaA. Ono will grant exclusive global licence rights, excluding Japan, South Korea, and Taiwan, to develop and commercialize its ONO-4641, a treatment for multiple...read more